Invicta Diagnostic Limited (NSEI: INVICTA)
Health Care · Health Care Providers & Services · IN
Rs73.00
-6.05% today · -24.5% 1Y
Invicta Diagnostic Limited (NSEI: INVICTA) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $9.62M.
Over the last twelve months the share price has lost 24.5%, trading between 58.10 and 105.00.
Tweenvest scores Invicta Diagnostic Limited across four factors: quality 67/100. Its strongest factor is quality.
INVICTA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.62M
- Revenue (TTM)
- $3.52M
- P/E
- 14.90
- EPS
- 4.90
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs105.00
- 52-week low
- Rs58.10
- Avg volume (3M)
- —
- Shares outstanding
- 12.57M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $359.94B | $401.01 | +1.11% |
| CVS Health CorporationNYSE: CVS | $120.63B | $94.32 | +1.53% |
| McKesson CorporationNYSE: MCK | $104.54B | $896.65 | -0.93% |
| HCA Healthcare, Inc.NYSE: HCA | $92.48B | $427.16 | -0.37% |
| Elevance Health, Inc.NYSE: ELV | $87.30B | $402.54 | +0.92% |
| The Cigna GroupNYSE: CI | $74.22B | $280.87 | +0.55% |
| Cencora, Inc.NYSE: COR | $62.55B | $327.79 | -0.08% |
| Cardinal Health, Inc.NYSE: CAH | $55.45B | $238.40 | +0.20% |
Figures last refreshed Aug 18, 2026.